Survey results show people living with HCV in the UK, the Netherlands and Belarus are less likely to be diagnosed than their global counterparts, increasing the possibility of liver disease, cirrhosis and liver cancer. Findings from HCV Quest, a global patient survey with 4,000 respondents from across the world, showed that half of people diagnosed with HCV reported that their doctors had initially failed to recognise symptoms and less than 46% were referred for a test.
14 April 2016 | World Hepatitis Alliance
Interview with Luis Mendão, chair of both the European AIDS Treatment Group (EATG) and Group of Activists on Treatments (GAT), a treatment activist group in Portugal.
14 April 2016 | BioMed Central blogs
Médecins du Monde (MdM) and Treatment Action Group (TAG) are pleased to announce the launch of mapCrowd (www.mapCrowd.org), an innovative online resource and data collection platform for gathering and sharing hepatitis C information.
09 February 2016 | Treatment Action Group
Our team in collaboration with the WHO Global Hepatitis Program is organizing an innovation contest on hepatitis B and C testing. The purpose of this contest is to identify innovative examples of delivering hepatitis B and C testing that will be highlighted within the 2016 WHO Hepatitis Testing Guidelines.
19 January 2016 | Social Entrepreneurship for Sexual Health
The benefits of screening prison inmates for infection with the hepatitis C virus and treating those who test positive for the infection would extend far beyond the prison population.
24 November 2015 | Eurekalert Inf Dis
Today, EASL and HIV in Europe announce a consensus definition of late presentation for viral hepatitis. The announcement coincides with the European AIDS Conference in Barcelona and aims to encourage policy makers, health professionals, public health institutions and civil society organisations to implement
this definition to improve the European surveillance of and response to the viral hepatitis epidemic.
26 October 2015 | EASL & HIV in Europe
A new study suggests massive under reporting may occur within the system set up by the US Centers for Disease Control and Prevention to estimate the incidence of acute hepatitis C virus infection. A research team found that less than 1 percent of a group of acute HCV patients in Massachusetts had been reported to the CDC, largely because required data was either not available or did not meet CDC definitions for acute HCV infection.
02 July 2015 | Eurekalert Inf Dis
This report, prepared by Professor David Goldberg and supported by Bristol Myers-Squibb, looks at the linkages between excessive alcohol consumption and hepatitis C, and explores how excessive alcohol consumption can act as a barrier to people with hepatitis C being considered for, receiving and the benefit of treatment for hepatitis C.
24 June 2015 | HCV Action
At this year's Digestive Disease Week, investigators discussed issues related to screening efforts, the natural history of HCV infection, the safety and efficacy of the next wave of antiviral agents, access to care, and affordability of treatment.
17 June 2015 | Medscape
The increase in reports reflects significant improvements in testing for hepatitis and other blood borne viruses (BBV) in prisons, which in a major change is moving from an ‘opt-in’ to an ‘opt-out’ policy to help reduce transmissions.
16 June 2015 | Public Health England press release